The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of the ApricityCare program for early detection and management of treatment-related adverse events in patients with metastatic cancer.
 
Lily Chen
No Relationships to Disclose
 
Mary Fulmer
Employment - Apricity Health
Stock and Other Ownership Interests - Apricity Health
 
Livia Ip
Employment - Apricity Health
Stock and Other Ownership Interests - Apricity Health
 
Lynda Chin
Employment - Apricity Health
Leadership - Bectas Therapeutics
Stock and Other Ownership Interests - Apricity Health; Bectas Therapeutics (I)
Consulting or Advisory Role - Bectas Therapeutics (I); Tvardi Therapeutics (I)
 
Sumit Subudhi
Stock and Other Ownership Interests - Apricity Health
Consulting or Advisory Role - Amgen; Apricity Health; Arcus Biosciences,; AstraZeneca; Baird; Bayer; Boxer Capital; Breaking Data; Bristol-Myers Squibb; Cancer Expert Now; ChemoCentryx; Clinical Comms Group; Dava Oncology; Dendreon; Hervolution Therapeutics; InProTher Janssen; Kahr Medical Ltd; Kiniksa; MacroGenics; MacroGenics; MD Education; Merck; Novartis; OncLive (owned by Intellisphere, LLC); Pfizer; Polaris; Portage Biotech; Regeneron; Rondo
Research Funding - AstraZeneca; Bristol-Myers Squibb; Janssen; Regeneron
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Regeneron
 
Bilal Siddiqui
Research Funding - Regeneron (Inst)